Wardwizard Healthcare clarifies ₹8 crore investment plan in AGM corrigendum
- Wardwizard Healthcare issued an AGM corrigendum on September 19, 2026, clarifying preferential issue objects
- ₹8 crore in proceeds will be invested exclusively in Wardwizard Medicare Private Limited
- Funds will subscribe to 2% Non-Cumulative Convertible Preference Shares for hospital expansion
- Company confirmed no proceeds will repay loans or obligations of promoter group entities
- The 42nd AGM is scheduled for September 30, 2026, via VC/OAVM

*this image is generated using AI for illustrative purposes only.
Wardwizard Healthcare Limited issued a corrigendum to its 42nd Annual General Meeting (AGM) notice on September 19, 2026. The update clarifies the utilization of proceeds from a proposed preferential issue of fully convertible warrants.
The company addressed a query from the Bombay Stock Exchange (BSE) dated September 17, 2026, by restating the object of the investment under Item No. 8 of the AGM Notice. This action ensures compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Investment Details
The corrigendum specifies that the entire amount of ₹8 crore proposed for investment will be directed exclusively to Wardwizard Medicare Private Limited (WMPL). The funds will be utilized for subscribing to 2% Non-Cumulative Convertible Preference Shares.
| Investment Parameter | Detail |
|---|---|
| Investee Company | Wardwizard Medicare Private Limited |
| Amount | ₹8 crore |
| Instrument | 2% Non-Cumulative Convertible Preference Shares |
| Purpose | Growth and expansion of hospital business |
WMPL currently operates four hospitals in Vadodara, Nadiad, Bharuch, and Dahej, along with one Ayurvedic Centre in Vadodara. The proposed capital infusion aims to support the growth, expansion, and development of these healthcare facilities.
Proceeds Utilization Restrictions
Wardwizard Healthcare explicitly confirmed that no portion of the preferential issue proceeds will be used for any other promoter or promoter group company. Furthermore, the funds will not be utilized, directly or indirectly, for the repayment of any loans, advances, financial assistance, dues, or other outstanding obligations of WMPL or any other related party.
This restriction covers obligations towards the company itself, its lenders, creditors, or other related parties. The utilization of proceeds remains subject to the Companies Act, 2013, SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, and other applicable laws.
Meeting Logistics
The 42nd AGM is scheduled for September 30, 2026, at 3:00 pm through Video Conferencing or Other Audio-Visual Means (VC/OAVM). The corrigendum forms an integral part of the original AGM Notice dated August 31, 2026. Members will receive the updated notice electronically via National Depository Services Limited (NSDL).
Historical Stock Returns for Wardwizard Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | +139.89% |
How might the exclusive allocation of ₹8 crore to Wardwizard Medicare Private Limited impact the parent company's liquidity and future capital raising strategies?
What is the expected timeline for the conversion of the 2% Non-Cumulative Convertible Preference Shares, and how could this affect existing shareholders' equity dilution?
Given the strict prohibition on using proceeds for debt repayment, what specific operational metrics or expansion milestones must WMPL achieve to justify this capital infusion?


































